Barclays’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7M Buy
1,125,105
+41,468
+4% +$467K ﹤0.01% 1019
2025
Q1
$10.3M Buy
1,083,637
+168,215
+18% +$1.59M ﹤0.01% 999
2024
Q4
$10.3M Buy
915,422
+641,646
+234% +$7.22M ﹤0.01% 1108
2024
Q3
$7.74M Buy
273,776
+176,445
+181% +$4.99M ﹤0.01% 1195
2024
Q2
$1.86M Sell
97,331
-52,295
-35% -$1,000K ﹤0.01% 1756
2024
Q1
$4.91M Sell
149,626
-107,673
-42% -$3.53M ﹤0.01% 1388
2023
Q4
$8.5M Buy
257,299
+127,318
+98% +$4.21M ﹤0.01% 1139
2023
Q3
$3.54M Buy
129,981
+29,672
+30% +$808K ﹤0.01% 1333
2023
Q2
$3.04M Buy
100,309
+31,440
+46% +$953K ﹤0.01% 1487
2023
Q1
$2.24M Sell
68,869
-25,273
-27% -$821K ﹤0.01% 1573
2022
Q4
$2.64M Buy
94,142
+58,588
+165% +$1.64M ﹤0.01% 1472
2022
Q3
$1.28M Buy
35,554
+9,623
+37% +$346K ﹤0.01% 1947
2022
Q2
$796K Sell
25,931
-11,631
-31% -$357K ﹤0.01% 2244
2022
Q1
$1.21M Sell
37,562
-86,667
-70% -$2.8M ﹤0.01% 2161
2021
Q4
$3.44M Buy
124,229
+63,967
+106% +$1.77M ﹤0.01% 1468
2021
Q3
$1.87M Buy
60,262
+35,308
+141% +$1.09M ﹤0.01% 1918
2021
Q2
$527K Sell
24,954
-53,860
-68% -$1.14M ﹤0.01% 2453
2021
Q1
$1.59M Buy
78,814
+36,642
+87% +$740K ﹤0.01% 2038
2020
Q4
$675K Sell
42,172
-8,694
-17% -$139K ﹤0.01% 2181
2020
Q3
$631K Sell
50,866
-9,475
-16% -$118K ﹤0.01% 2190
2020
Q2
$430K Sell
60,341
-310,168
-84% -$2.21M ﹤0.01% 2407
2020
Q1
$2.01M Buy
370,509
+295,933
+397% +$1.61M ﹤0.01% 1333
2019
Q4
$674K Sell
74,576
-46,400
-38% -$419K ﹤0.01% 2525
2019
Q3
$871K Sell
120,976
-1,474
-1% -$10.6K ﹤0.01% 2335
2019
Q2
$972K Buy
122,450
+93,864
+328% +$745K ﹤0.01% 2355
2019
Q1
$359K Sell
28,586
-32,419
-53% -$407K ﹤0.01% 2768
2018
Q4
$1.22M Sell
61,005
-69,908
-53% -$1.39M ﹤0.01% 1689
2018
Q3
$3.72M Buy
130,913
+23,567
+22% +$669K ﹤0.01% 1269
2018
Q2
$2.26M Sell
107,346
-7,420
-6% -$156K ﹤0.01% 1370
2018
Q1
$1.64M Buy
114,766
+38,151
+50% +$544K ﹤0.01% 1489
2017
Q4
$942K Buy
76,615
+75,371
+6,059% +$927K ﹤0.01% 1680
2017
Q3
$22K Sell
1,244
-25,516
-95% -$451K ﹤0.01% 3182
2017
Q2
$679K Sell
26,760
-15,090
-36% -$383K ﹤0.01% 1760
2017
Q1
$934K Sell
41,850
-76,882
-65% -$1.72M ﹤0.01% 1603
2016
Q4
$1.76M Buy
118,732
+79,326
+201% +$1.17M ﹤0.01% 1220
2016
Q3
$970K Buy
39,406
+31,906
+425% +$785K ﹤0.01% 1432
2016
Q2
$144K Buy
+7,500
New +$144K ﹤0.01% 2225